Reduced prevalence of asthma | 1: The proportion of people who report having current and long-term asthma | 11% of people in Australia in 2017–18 | 11% of people in Australia in 2020–21 | Data not comparable
| 30 June 2023 View data source for prevalence |
Improved quality of life among people with asthma | 2: Impact of asthma on quality of life | 23% of people with asthma reported that asthma interfered with their daily activities 2 or more times in the past 4 weeks in 2017–18 | 21% of people with asthma reported that interfered with their daily activities 2 or more times in the past 4 weeks in 2020–21 | Data not comparable
| 30 June 2023 View data source for quality-of-life measures |
11% of people with asthma reported experiencing very high levels of psychological distress in 2017–18 | 11% of people with asthma reported experiencing very high levels of psychological distress in 2020–21 | Data not comparable
| 30 June 2023 View data source for quality-of-life measures |
8% of people with asthma reported having poor self-assessed health in 2017–18 | 5% of people with asthma reported having poor self-assessed health in 2020–21 | Data not comparable
| 30 June 2023 View data source for quality-of-life measures |
Reduced costs of asthma to patients, the healthcare system and government, including indirect costs such as reduced productivity | 3: Annual health expenditure on asthma | $770.4 million in 2015–16 | $851.7 million in 2020–21 | Regress
| 14 December 2023 View data source for health expenditure |
Reduced asthma-related deaths | 4: Deaths due to asthma | 1.9 deaths per 100,000 population for all ages in 2017 (456 deaths) | 1.4 deaths per 100,000 population for all ages in 2021 (351 deaths) | Progress
| 30 June 2023 View data source for deaths |
The death rate due to asthma for people aged 5–34, was 0.3 per 100,000 population in 2017 | The death rate due to asthma for people aged 5–34, was 0.2 per 100,000 population in 2021 | Progress
| 30 June 2023 View data source for deaths |
The death rate due to asthma for people aged 35–54, was 1.0 per 100,000 population in 2017 | The death rate due to asthma for people aged 35–54, was 0.4 per 100,000 population in 2021 | Progress
| 30 June 2023 View data source for deaths |
The death rate due to asthma for people aged 55 and over, was 5.5 per 100,000 population in 2017 | The death rate due to asthma for people aged 55 and over, was 4.1 per 100,000 population in 2021 | Progress
| 30 June 2023 View data source for deaths |
Decrease in suboptimal asthma control | 5: Asthma control medication use | 17% of people dispensed at least 1 SABA, were dispensed 3 or more SABA in 2017–18 | 18% of people dispensed at least 1 SABA, were dispensed 3 or more SABA in 2021–22 | No change
| 30 June 2023 View data source for asthma control medications |
Improved adherence with appropriate preventer medicines | 6: Preventer medication use for asthma | 34% dispensed at least 1 preventer, were dispensed 3 or more preventers in 2017–18 | 33% dispensed at least 1 preventer, were dispensed 3 or more preventers in 2021–22 | No change
| 30 June 2023 View data source for preventer medication |
Increase in annual General Practitioner (GP) reviews of people with asthma | 7: Asthma cycle of care claims | 0.3% of people in Australia claimed in 2017–18 | 0.1% of people in Australia claimed in 2021–22 | Regress
| 30 June 2023 View data source for asthma cycle of care claims |
Increase in asthma action plan uptake for both adults and children | 8: Asthma action plans | 31% of people with asthma had a plan in 2017–18 | 34% of people with asthma had a plan in 2021–22 | Data not comparable
| 30 June 2023 View data source for asthma action plans |
Reduced asthma-related hospitalisations | 9: Hospital admissions due to asthma | 172 per 100,000 asthma hospitalisations in 2016–17 | 99 per 100,000 asthma hospitalisations in 2021–22 | Progress
| 14 December 2023 View data source for asthma hospitalisations |
Reduced asthma-related hospitalisations | 10: Emergency department (ED) presentations | 297 per 100,000 ED presentations in 2018–19 due to asthma | 232 per 100,000 ED presentations in 2020–21 due to asthma | Progress
| 30 June 2023 View data source for asthma ED presentations |